CSIMarket
 
Windtree Therapeutics Inc  (WINT)
 

News




Windtree Renews Collaboration with Chang Gung University to Advance SERCA2a Research in Cardiovascular Therapies

Windtree Therapeutics Partners with Ladenburg Thalmann & Co. to Unlock Stockholder Value and Eliminate Million-Dollar Liability

Windtree Successfully Eliminates $15 Million Contingent Liability to Deerfield Management Company

Windtree Therapeutics Expands Presence in Asia-Pacific through Licensing Agreement with Lees Pharmaceuticals

Unveiling Istaroxime: A Pure SERCA2a Activator with Game-Changing Potential in Arrhythmia Treatment

Windtree Therapeutics* SEISMiC Extension Study Shows Potential Breakthrough in Treating Early Cardiogenic Shock

Unveiling Windtree Therapeutics* Revolutionary Patent: A New Era in Heart Failure Treatments

Windtree Therapeutics Inc Emerges Strong Despite $4.69 Million Operating Shortfall

The rising corporation from the Biotechnology & Pharmaceuticals sector the Windtree Therapeutics Inc reported the fiscal interval ending second quarter of 2023, results

Windtree Therapeutics Inc Reports Significant Improvement in Financial Performance, Reducing Operating Shortfall to $-4.191 Million in Q1 2023

In the fiscal interval ending fourth quarter of 2022 operating loss echoed some improvement to $-14.692 millions, at the Biotechnology & Pharmaceuticals company

In the most recent fiscal period operating loss reflected some improvement to $-8.147 millions, at the Biotechnology & Pharmaceuticals company

In the most recent fiscal period operating shortfall showed enhancement to $-45.362 million, at the Windtree Therapeutics Inc









Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com